Study reveals the advantages and pitfalls of adding a TKI to a monoclonal antibody after chemoradiation for non-small cell ...

AstraZeneca’s share price has fallen a lot from its September high, but this could mean a tremendous opportunity for me to ...

Cancer researchers discovered how exercise really can be like a drug for colon cancer, and AstraZeneca's immunotherapy drug ...

An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...

Soros Fund Management's 13F portfolio grew slightly to $6.70B in Q1 2025. Check out the significant new stakes and major ...

In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding ...

AstraZeneca exercises option to license the first candidate from the IBD joint research program for further development and commercialization Achievement of second significant research milestone in ...

Merck’s Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety and promising objective response rates in patients with few treatment choices ...

The Computer Weekly Developer Network went to AeraHUB 25 London this week, a “decision intelligence event” hosted by Aera, an ...

Quantum computing company IonQ (NYSE:IONQ) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales ...

India is witnessing a rise in Covid-19 infections surpassing 7,000 cases amid seasonal viral outbreaks. Testing rates are ...